Wakazono Y, Kiyatkin E A
Behavioral Neuroscience Branch, National Institute on Drug Abuse-Intramural Research Program, National Institutes of Health, DHHS, 5500 Nathan Shock Drive, Baltimore, MD 21224, USA.
Neuroscience. 2008 Feb 6;151(3):824-35. doi: 10.1016/j.neuroscience.2007.11.034. Epub 2007 Dec 3.
Cocaine effectively inhibits dopamine (DA) uptake and this action appears to be the primary cause for increased DA transmission following systemic cocaine administration. Although this action had been reliably demonstrated in vivo with cocaine at high doses, data on the extent and the time-course of DA uptake inhibition induced by i.v. cocaine at low, reinforcing doses remain controversial. To clarify this issue, we examined how cocaine affects striatal neuronal responses to repeated iontophoretic DA applications in urethane-anesthetized rats. Because most striatal neurons during anesthesia have low, sporadic activity, DA tests were performed on cells tonically activated by continuous glutamate application. DA phasically decreased the activity of most dorsal and ventral striatal neurons; these responses in control conditions (i.v. saline) were current (dose) -dependent and remained highly stable following repeated DA applications at the same currents. DA also consistently decreased the activity of striatal neurons after i.v. cocaine (1 mg/kg); the magnitude of DA-induced inhibition slowly increased from approximately 5 min, became significantly larger from approximately 9 min, and peaked at 13-15 min after a single i.v. injection. Then, the difference in the DA response slowly decreased toward the pre-cocaine baseline. A similar enhancement of DA induced-inhibition was also seen after i.p. cocaine administration at a high dose (15 mg/kg). In this case, the DA response became significantly stronger at 7-9 min and remained enhanced vs. a pre-drug control up to 24-26 min after the injection. Both regimens of cocaine treatment did not result in evident changes in either onset or offset of the DA-induced inhibitions. Our data confirm that cocaine at low, reinforcing doses inhibits DA uptake, resulting in potentiation of DA-induced neuronal inhibitions, but they suggest that this effect is relatively weak and delayed from the time of i.v. injection. These slow and prolonged effects of i.v. cocaine on DA-induced neuronal responses are consistent with previous binding and our electrochemical evaluations of DA uptake, presumably reflecting the total time necessary for i.v.-delivered cocaine to reach brain microvessels, cross the blood-brain barrier, passively diffuse within brain tissue, interact with the DA transporters, and finally inhibit DA uptake.
可卡因能有效抑制多巴胺(DA)的摄取,这一作用似乎是全身给予可卡因后DA传递增加的主要原因。尽管高剂量可卡因在体内的这一作用已得到可靠证实,但关于静脉注射低剂量、能产生强化作用的可卡因所诱导的DA摄取抑制程度及时间进程的数据仍存在争议。为阐明这一问题,我们研究了在乌拉坦麻醉的大鼠中,可卡因如何影响纹状体神经元对重复离子电泳施加DA的反应。由于麻醉期间大多数纹状体神经元活动较低且呈散发性,因此DA测试是在通过持续施加谷氨酸而被持续激活的细胞上进行的。DA能阶段性地降低大多数背侧和腹侧纹状体神经元的活动;在对照条件下(静脉注射生理盐水),这些反应与电流(剂量)相关,并且在相同电流下重复施加DA后仍保持高度稳定。静脉注射可卡因(1mg/kg)后,DA也持续降低纹状体神经元的活动;DA诱导的抑制幅度从约5分钟开始缓慢增加,从约9分钟起显著增大,并在单次静脉注射后13 - 15分钟达到峰值。然后,DA反应的差异朝着可卡因给药前的基线缓慢下降。高剂量(15mg/kg)腹腔注射可卡因后,也观察到类似的DA诱导抑制增强。在这种情况下,DA反应在7 - 9分钟时显著增强,并且在注射后长达24 - 26分钟内相对于给药前对照仍保持增强。两种可卡因治疗方案均未导致DA诱导抑制的起始或结束出现明显变化。我们的数据证实,低剂量、能产生强化作用的可卡因会抑制DA摄取,导致DA诱导的神经元抑制增强,但表明这种作用相对较弱且在静脉注射后延迟出现。静脉注射可卡因对DA诱导的神经元反应的这些缓慢且持久的作用与先前关于DA摄取的结合及我们的电化学评估结果一致,推测这反映了静脉注射的可卡因到达脑微血管、穿过血脑屏障、在脑组织中被动扩散、与DA转运体相互作用并最终抑制DA摄取所需的总时间。